vimarsana.com

Latest Breaking News On - Stelis biopharma ltd - Page 1 : vimarsana.com

Syngene Q3 net profit up marginally - The Hindu BusinessLine

Syngene Q3 net profit up marginally - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd

Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

syngene q2 results: Syngene Q2 Results: Net profit jumps 14% to Rs 117 crore

Net profit before an exceptional item rose 20% YoY to 122 crore. The exceptional item pertains to transaction costs relating to the acquisition of the multi-modal facility of Stelis Biopharma

Syngene International Q2 net profit rises 14 22% to Rs 116 5 crore

The company had posted a consolidated net profit of Rs 102 crore in the year-ago period, Syngene International said in a regulatory filing.

Syngene Q2 net profit up 14 % at ₹117 cr - The Hindu BusinessLine

Syngene Q2 net profit up 14 % at ₹117 cr - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.